Clincosm LogoSign in Get a demo

Graft Versus Host Disease

Showing NaN - NaN of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD Trial in Chicago (Expressive Writing)

Not yet recruiting
  • Graft Versus Host Disease
  • Expressive Writing
  • Chicago, Illinois
    Department of Dermatology, Northwestern University Feinberg Scho
Jan 12, 2023

GVHD Trial in United States (Abatacept)

Recruiting
  • Graft Versus Host Disease
  • Birmingham, Alabama
  • +8 more
Mar 16, 2022

GVHD Trial in United States (pentostatin)

Completed
Has Results
  • Graft Versus Host Disease
  • Lewes, Delaware
  • +15 more
Oct 5, 2021

Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

Active, not recruiting
  • Sickle Cell Disease
  • Graft Versus Host Disease
  • Washington, District of Columbia
  • +6 more
Aug 4, 2021

B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, GVHD Trial in Australia,

Completed
Has Results
  • B-cell Childhood Acute Lymphoblastic Leukemia
  • +5 more
  • Phoenix, Arizona
  • +49 more
Jul 24, 2019

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in United States (cyclosporine ophthalmic emulsion, )

Completed
Has Results
  • Chronic Myeloproliferative Disorders
  • +6 more
  • cyclosporine ophthalmic emulsion
  • placebo
  • Palo Alto, California
  • +4 more
Jan 24, 2017

GVHD, Lymphoma Trial in United States (carmustine, melphalan, etoposide)

Completed
  • Graft Versus Host Disease
  • Lymphoma
  • Birmingham, Alabama
  • +47 more
Jul 15, 2016

Preleukemia, Myeloproliferative Disorders, Lymphoma Trial in Chicago (Fludarabine, Melphalan, Campath)

Terminated
  • Preleukemia
  • +4 more
  • Chicago, Illinois
    The Uniiversity of Chicago
Mar 14, 2014

GVHD Trial in Worldwide (cyclosporine, hydroxychloroquine, prednisone)

Completed
  • Graft Versus Host Disease
  • Tucson, Arizona
  • +103 more
Feb 12, 2014

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Chicago (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +7 more
  • anti-thymocyte globulin
  • +8 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

Chronic Myeloproliferative Disorders, GVHD, Leukemia Trial in Chicago (biological, drug, procedure)

Completed
  • Chronic Myeloproliferative Disorders
  • +6 more
  • filgrastim
  • +5 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center, Northwestern Univer
May 31, 2012

GVHD, Leukemia, Lymphoma Trial in United States (biological, drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +4 more
  • anti-thymocyte globulin
  • +6 more
  • Gainesville, Florida
  • +16 more
Mar 3, 2011

GVHD, Leukemia, MDS Trial in United States (biological, drug, procedure, radiation)

Completed
  • Graft Versus Host Disease
  • +3 more
  • anti-thymocyte globulin
  • +7 more
  • Gainesville, Florida
  • +14 more
Mar 3, 2011

GVHD, Cancer, Stem Cell Transplantation Trial in Chicago (Extracorporeal Photopheresis)

Unknown status
  • Graft Versus Host Disease
  • +2 more
  • Extracorporeal Photopheresis
  • Chicago, Illinois
    Children's Memorial Hospital
Oct 7, 2010

GVHD Trial in United States (MEDI-507)

Completed
  • Graft Versus Host Disease
  • Birmingham, Alabama
  • +5 more
Dec 19, 2008

GVHD, Aplastic Anemia Trial in Chicago (anti-thymocyte globulin, cyclophosphamide, cyclosporine)

Unknown status
  • Graft Versus Host Disease
  • Aplastic Anemia
  • anti-thymocyte globulin
  • +4 more
  • Chicago, Illinois
    Northwestern Memorial Hospital
Jun 23, 2005